The Resistance and Immune Response to Palbociclib in Breast Cancer
Clinical trial NCT03401359 · UNKNOWN
Trial details
- NCT number
- NCT03401359
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-24
- Primary completion
- 2020-10-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.